Jan Schnitzer

Jan Schnitzer

Company: Proteogenomics Research Institute For Systems Medicine

Job title: Founder, Chief Executive Officer & Institute Director


Reimagining Precision Delivery to Enable TGF-β Therapies at Ultra-Low, Nontoxic Doses 9:30 am

Proving how endothelium is the critical barrier to low dose precision therapeutic efficacy without toxicities New dual precision therapeutics to penetrate endothelium and to fully block TGF-β only inside the lung Transvascular pumping of drugs by design boosts site delivery and potency 1000x and circumnavigates toxicity New Data!Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.